keyword
MENU ▼
Read by QxMD icon Read
search

edss

keyword
https://www.readbyqxmd.com/read/28933245/therapy-of-highly-active-pediatric-multiple-sclerosis
#1
Peter Huppke, Brenda Huppke, David Ellenberger, Kevin Rostasy, Hannah Hummel, Wiebke Stark, Wolfgang Brück, Jutta Gärtner
OBJECTIVE: Study aims were to determine the frequency of highly active disease in pediatric multiple sclerosis (MS), the response to natalizumab (NTZ) and fingolimod (FTY) treatment, and the impact of current treatment modalities on the clinical course. METHODS: Retrospective single-center study in the German Center for MS in Childhood and Adolescence. RESULTS: Of 144 patients with first MS manifestation between 2011 and 2015, 41.6% fulfilled the criteria for highly active MS...
September 1, 2017: Multiple Sclerosis: Clinical and Laboratory Research
https://www.readbyqxmd.com/read/28933233/optical-coherence-tomography-angiography-retinal-vascular-network-assessment-in-multiple-sclerosis
#2
Roberta Lanzillo, Gilda Cennamo, Chiara Criscuolo, Antonio Carotenuto, Nunzio Velotti, Federica Sparnelli, Alessandra Cianflone, Marcello Moccia, Vincenzo Brescia Morra
BACKGROUND: Optical coherence tomography (OCT) angiography is a new method to assess the density of the vascular networks. Vascular abnormalities are considered involved in multiple sclerosis (MS) pathology. OBJECTIVE: To assess the presence of vascular abnormalities in MS and to evaluate their correlation to disease features. METHODS: A total of 50 MS patients with and without history of optic neuritis (ON) and 46 healthy subjects were included...
September 1, 2017: Multiple Sclerosis: Clinical and Laboratory Research
https://www.readbyqxmd.com/read/28928709/insight-into-metabolic-1-h-mrs-changes-in-natalizumab-induced-progressive-multifocal-leukoencephalopathy-brain-lesions
#3
Ruth Schneider, Barbara Bellenberg, Robert Hoepner, Gisa Ellrichmann, Ralf Gold, Carsten Lukas
BACKGROUND: Progressive multifocal leukoencephalopathy (PML) is a severe complication of immunosuppressive therapies, especially of natalizumab in relapsing-remitting multiple sclerosis (MS). Metabolic changes within PML lesions have not yet been described in natalizumab-associated PML in MS patients. OBJECTIVE: To study metabolic profiles in natalizumab-associated PML lesions of MS patients by (1)H magnetic resonance spectroscopy ((1)H-MRS) at different stages during the PML course...
2017: Frontiers in Neurology
https://www.readbyqxmd.com/read/28912625/cognitive-impairment-in-relapsing-remitting-multiple-sclerosis-patients-with-very-mild-clinical-disability
#4
S Migliore, A Ghazaryan, I Simonelli, P Pasqualetti, F Squitieri, G Curcio, D Landi, M G Palmieri, F Moffa, M M Filippi, F Vernieri
Cognitive dysfunction affects 40-65% of multiple sclerosis (MS) patients and can occur in the early stages of the disease. This study aimed to explore cognitive functions by means of the Italian version of the minimal assessment of cognitive function in MS (MACFIMS) in relapsing-remitting MS (RRMS) patients with very mild clinical disability to identify the primarily involved cognitive functions. Ninety-two consecutive RRMS patients with Expanded Disability Status Scale (EDSS) scores ≤ 2.5 and forty-two healthy controls (HC) were investigated...
2017: Behavioural Neurology
https://www.readbyqxmd.com/read/28906340/contemporary-approach-to-joint-hypermobility-and-related-disorders
#5
Marco Castori, Alan Hakim
PURPOSE OF REVIEW: Joint hypermobility is a common, although largely ignored physical sign. Joint hypermobility is often asymptomatic but may be a feature of an underlying genetic disorder with systemic manifestations. The present article presents a comprehensive approach to considering joint hypermobility and clinically related issues in children and adults. RECENT FINDINGS: Ehlers-Danlos syndrome (EDS) is an umbrella term for various Mendelian connective tissue disorders sharing joint hypermobility, skin hyperextensibility, and tissue fragility...
September 12, 2017: Current Opinion in Pediatrics
https://www.readbyqxmd.com/read/28899746/performance-of-five-research-domain-automated-wm-lesion-segmentation-methods-in-a-multi-center-ms-study
#6
Alexandra de Sitter, Martijn D Steenwijk, Aurélie Ruet, Adriaan Versteeg, Yahou Liu, Ronald A van Schijndel, Petra J W Pouwels, Iris D Kilsdonk, Keith S Cover, Bob W van Dijk, Stefan Ropele, Maria A Rocca, Marios Yiannakas, Mike P Wattjes, Soheil Damangir, Giovanni B Frisoni, Jaume Sastre-Garriga, Alex Rovira, Christian Enzinger, Massimo Filippi, Jette Frederiksen, Olga Ciccarelli, Ludwig Kappos, Frederik Barkhof, Hugo Vrenken
BACKGROUND AND PURPOSE: In vivoidentification of white matter lesions plays a key-role in evaluation of patients with multiple sclerosis (MS). Automated lesion segmentation methods have been developed to substitute manual outlining, but evidence of their performance in multi-center investigations is lacking. In this work, five research-domain automated segmentation methods were evaluated using a multi-center MS dataset. METHODS: 70 MS patients (median EDSS of 2...
September 9, 2017: NeuroImage
https://www.readbyqxmd.com/read/28898787/theoretical-investigation-of-the-%C3%AF-%C3%AF-stacking-interactions-in-substituted-pyridinium-ion
#7
Abolfazl Azizi, Ali Ebrahimi
The interaction between positively charged aromatic groups (π(+)-π(+)) is characterized by stacked pyridinium ion derivatives X-PyH(+)||X-PyH(+) (XH, NH2, OH, CN, F, Br and Cl) at the M06-2X/6-311++G(d,p) level of theory in the presence of three solvents. The results indicate the formation of π(+)-π(+) stacking in a dielectric solvent can be due to the significant stability of the charge-charge repulsion forces. The trend in the absolute value of stacking interaction energy |ΔEπ(+)⋯π(+)| with respect to the solvent is formamide>water>acetone...
September 4, 2017: Journal of Molecular Graphics & Modelling
https://www.readbyqxmd.com/read/28898535/characterization-of-social-cognition-impairment-in-multiple-sclerosis
#8
Mireille Neuhaus, Sara Bagutti, Özgür Yaldizli, Dominik Zwahlen, Simeon Schaub, Bettina Frey, Bettina Fischer-Barnicol, Jean-Marc Burgunder, Marie-Dominique Martory, Jana Pöttgen, Jean-Marie Annoni, Iris-Katharina Penner
BACKGROUND: Multiple sclerosis (MS) has been associated with deficits in social cognition. However, little is known about which domains of social cognition are predominantly affected and what other factors are associated with it. OBJECTIVES: 1) To characterize social cognition deficit in a group of MS outpatients. 2) To relate impairment in social cognition to overall cognitive status, depression and fatigue. METHODS: Thirty-five MS patients (mean disease duration 12...
September 12, 2017: European Journal of Neurology: the Official Journal of the European Federation of Neurological Societies
https://www.readbyqxmd.com/read/28894919/-timed-up-and-go-and-brain-atrophy-a-preliminary-mri-study-to-assess-functional-mobility-performance-in-multiple-sclerosis
#9
Lorena Lorefice, G Coghe, G Fenu, M Porta, G Pilloni, J Frau, F Corona, V Sechi, M A Barracciu, M G Marrosu, M Pau, E Cocco
Motor and cognitive disabilities are related to brain atrophy in multiple sclerosis (MS). 'Timed up and go' (TUG) has been recently tested in MS as functional mobility test, as it is able to evaluate ambulation/coordination-related tasks, as well as cognitive function related to mobility. The objective of this study is to evaluate the relationship between brain volumes and TUG performances. Inclusion criteria were a diagnosis of MS and the ability to walk at least 20 m. TUG was performed using a wearable inertial sensor...
September 11, 2017: Journal of Neurology
https://www.readbyqxmd.com/read/28894553/effect-of-alpha-lipoic-acid-on-asymmetric-dimethylarginine-and-disability-in-multiple-sclerosis-patients-a-randomized-clinical-trial
#10
Mohammad Khalili, Madjid Soltani, Shirin Amiri Moghadam, Parvin Dehghan, Amirreza Azimi, Omid Abbaszadeh
BACKGROUND: Multiple Sclerosis (MS) is an inflammatory and demyelinating disease of the central nervous system. Oxidative stress plays a major role in the onset and progression of MS. Asymmetric dimethylarginine (ADMA) formation is dependent on oxidative stress status. OBJECTIVE: We examined whether alpha-lipoic acid (ALA) as a potent antioxidant could improve the Expanded Disability Status Scale (EDSS) and decrease plasma level of ADMA in multiple sclerosis patients...
July 2017: Electronic Physician
https://www.readbyqxmd.com/read/28878471/test-retest-reliability-of-static-postural-control-in-people-with-multiple-sclerosis
#11
Maria Mercedes Reguera-García, Fernanda de Souza-Teixeira, Jose Antonio de Paz Fernández
[Purpose] The purpose of this study was to analyse the intraday test-retest reliability of stabilometric measurements on the Centre of Pressure (CoP) in persons with Multiple Sclerosis. [Subjects and Methods] The measurements were taken with the subject standing on the force platform with both feet together, in four different conditions: eyes open and closed whilst standing on both a rigid surface and then on foam. The measurements were taken on three occasions with intervals of 20 minutes between them. 18 persons with confirmed Multiple Sclerosis (MS), (aged 44...
August 2017: Journal of Physical Therapy Science
https://www.readbyqxmd.com/read/28870573/cxcl10-and-cxcl13-chemokines-in-patients-with-relapsing-remitting-and-primary-progressive-multiple-sclerosis
#12
Piotr Iwanowski, Jacek Losy, Lucyna Kramer, Marlena Wójcicka, Elżbieta Kaufman
OBJECTIVES: Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system characterized by a variable clinical course. Different pathogenic mechanisms responsible for relapsing remitting (RRMS) and primary progressive multiple sclerosis (PPMS) are modulated by immunological process with important role of chemokine network. CXCL10 and CXCL13 chemokines act as chemoattractants and modulators of proinflammatory reactions promoting process of demyelination...
September 15, 2017: Journal of the Neurological Sciences
https://www.readbyqxmd.com/read/28865413/correlation-of-serum-levels-of-il-33-il-37-soluble-form-of-vascular-endothelial-growth-factor-receptor-2-vegfr2-and-circulatory-frequency-of-vegfr2-expressing-cells-with-multiple-sclerosis-severity
#13
Ebrahim Kouchaki, Omid Reza Tamtaji, Ehsan Dadgostar, Mohammad Karami, Hassan Nikoueinejad, Hossein Akbari
IL-33 and IL-37 (new cytokines of IL-1 family), soluble form of vascular endothelial growth factor receptor-2 (sVEGFR2) as well as membranous expression of VEGFR2 have some key roles in the pathogenesis of autoimmune and inflammatory diseases. The aim of this study was to correlate circulatory changes of these factors with the severity of multiple sclerosis (MS) as an autoimmune and inflammatory disease. Our case-control study was performed on 84 patients with MS and 75 healthy subjects. The serum levels of IL-33, IL-37 and sVEGFR2 in the peripheral blood samples of all participants were measured by enzyme-linked immune sorbent assay (ELISA)...
August 2017: Iranian Journal of Allergy, Asthma, and Immunology
https://www.readbyqxmd.com/read/28863008/olfactory-dysfunction-associated-with-neuro-beh%C3%A3-et-disease
#14
Remzi Doğan, Burak Ertaş, Berke Özücer, Erkingul Birday, Orhan Özturan, Bayram Veyseller
INTRODUCTION: Neurologic involvement associated with Behçet disease (BD) is defined as a different entity: Neuro-Behçet disease (NBD). Behçet disease presents with olfactory dysfunction. It is not known whether this is the consequence of mucosal involvement or neurologic involvement. OBJECTIVE: The aim of this study was to investigate whether olfactory dysfunction was further aggravated as the result of neurologic involvement. METHODS: Sixteen patients diagnosed with NBD and 16 healthy control patients with similar demographic characteristics were recruited as the healthy control group...
August 31, 2017: Journal of Craniofacial Surgery
https://www.readbyqxmd.com/read/28836398/vdr-and-cyp24a1-expression-analysis-in-iranian-relapsing-remitting-multiple-sclerosis-patients
#15
Hashem Sadeghi, Mohammad Taheri, Elham Sajadi, Abolfazl Movafagh, Shahram Arsang Jang, Arezou Sayad
OBJECTIVES: Multiple sclerosis (MS) is a common disease of the central nervous system.This disease may be initiated by either vitamin deficiency or triggered by abnormality in CYP24A1 and vitamin D receptor. MATERIALS AND METHODS: In this case-control study, the expression of genes encoding vitamin D receptor (VDR) and CYP24A1 in relapsing-remitting MS (RR-MS) patients was compared with normal individuals in the Iranian population. RNA from whole blood of 50 RR-MS patients (HLA-DRB1*15-negative and responders to interferonbeta with a normal vitamin D level) and 50 normal controls was extracted...
October 2017: Cell Journal
https://www.readbyqxmd.com/read/28835746/effect-of-cognitive-demand-on-functional-mobility-in-ambulatory-individuals-with-multiple-sclerosis
#16
Marcia Aparecida Ciol, Patricia Noritake Matsuda, Seema Rani Khurana, Melissa Jaclyn Cline, Jacob Jonathan Sosnoff, George Howard Kraft
BACKGROUND: As disease progresses, cognitive demands may affect functional mobility in individuals with multiple sclerosis (MS). The Timed Up and Go (TUG) test assesses functional mobilityin populationssuch as MS. A cognitive-demanding task can be added to the TUG test to assess its effect on functional mobility. METHODS: People with MS (n = 52) and controls (n = 57) performed three versions of the TUG test: TUG alone (TUG-alone), TUG plus reciting the alphabet (TUG-alpha), and TUG plus subtracting numbers by 3s (TUG-3s)...
July 2017: International Journal of MS Care
https://www.readbyqxmd.com/read/28835403/alemtuzumab-care-ms-ii-5-year-follow-up-efficacy-and-safety-findings
#17
Alasdair J Coles, Jeffrey A Cohen, Edward J Fox, Gavin Giovannoni, Hans-Peter Hartung, Eva Havrdova, Sven Schippling, Krzysztof W Selmaj, Anthony Traboulsee, D Alastair S Compston, David H Margolin, Karthinathan Thangavelu, Madalina C Chirieac, Darlene Jody, Panos Xenopoulos, Richard J Hogan, Michael A Panzara, Douglas L Arnold
OBJECTIVE: To evaluate 5-year efficacy and safety of alemtuzumab in patients with active relapsing-remitting multiple sclerosis and inadequate response to prior therapy. METHODS: In the 2-year Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis (CARE-MS) II study (NCT00548405), alemtuzumab-treated patients received 2 courses (baseline and 12 months later). Patients could enter an extension (NCT00930553), with as-needed alemtuzumab retreatment for relapse or MRI activity...
September 12, 2017: Neurology
https://www.readbyqxmd.com/read/28835401/alemtuzumab-care-ms-i-5-year-follow-up-durable-efficacy-in-the-absence-of-continuous-ms-therapy
#18
RANDOMIZED CONTROLLED TRIAL
Eva Havrdova, Douglas L Arnold, Jeffrey A Cohen, Hans-Peter Hartung, Edward J Fox, Gavin Giovannoni, Sven Schippling, Krzysztof W Selmaj, Anthony Traboulsee, D Alastair S Compston, David H Margolin, Karthinathan Thangavelu, Claudio E Rodriguez, Darlene Jody, Richard J Hogan, Panos Xenopoulos, Michael A Panzara, Alasdair J Coles
OBJECTIVE: To evaluate 5-year efficacy and safety of alemtuzumab in treatment-naive patients with active relapsing-remitting MS (RRMS) (CARE-MS I; NCT00530348). METHODS: Alemtuzumab-treated patients received treatment courses at baseline and 12 months later; after the core study, they could enter an extension (NCT00930553) with as-needed alemtuzumab retreatment for relapse or MRI activity. Assessments included annualized relapse rate (ARR), 6-month confirmed disability worsening (CDW; ≥1-point Expanded Disability Status Scale [EDSS] score increase [≥1...
September 12, 2017: Neurology
https://www.readbyqxmd.com/read/28834557/association-of-cyp2r1-rs10766197-with-ms-risk-and-disease-progression
#19
Concetta Scazzone, Luisa Agnello, Paolo Ragonese, Bruna Lo Sasso, Chiara Bellia, Giulia Bivona, Rosaria Schillaci, Giuseppe Salemi, Marcello Ciaccio
BACKGROUND: MS is a neurodegenerative autoimmune disease resulting from a complex interaction of genetic and environmental factors. Among these, vitamin D and genetic variants associated with vitamin D-metabolism gain great attention. The aim of our study was to assess five SNPs in NADSYN1 and CYP2R1 genes in relation to serum 25-OH-vitamin D3 levels in MS patients and controls. METHODS: 25-OH-vitamin D3 levels and genotyping of CYP2R1- and NADSYN1-SNPs were investigated both in MS patients and in healthy controls...
August 23, 2017: Journal of Neuroscience Research
https://www.readbyqxmd.com/read/28831548/comparison-of-the-efficacy-of-azathioprine-and-rituximab-in-neuromyelitis-optica-spectrum-disorder-a-randomized-clinical-trial
#20
Zahra Nikoo, Shervin Badihian, Vahid Shaygannejad, Nasrin Asgari, Fereshteh Ashtari
Neuromyelitis optica spectrum disorder (NMOSD) often follows a relapsing course. As disability in NMOSD is attack-related, effective treatments are needed. We aimed to compare the efficacy of azathioprine (AZA) and rituximab (RIT) as maintenance therapy in NMOSD patients. An open, randomized clinical trial was conducted during September 2015 to December 2016, in Isfahan, Iran. Initially, 100 NMOSD patients were approached, 86 entered the study, and 68 cases completed the trial. All patients had a relapsing-remitting course with expanded disability extended scale (EDSS) ≤7 (median 2...
August 22, 2017: Journal of Neurology
keyword
keyword
84088
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"